Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid cddo-me in prostate cancer

Yongbo Liu, Xiaohua Gao, Dorrah Deeb, Ali Syed Arbab, Subhash C. Gautam

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Methyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate (CDDO-Me) is an synthetic oleanane triterpenoid with strong antiprolifertive and proapoptotic activities in cancer cells. However, the effect of CDDO-Me on human telomerase reverse transcriptase (hTERT) and its telomerase activity in prostate cancer cells has not been studied. We investigated the role of hTERT in mediating the anticancer activity of CDDO-Me in prostate cancer cells in vitro and in vivo. The inhibition of cell proliferation and induction of apoptosis by CDDO-Me in LNCaP and PC-3 prostate cancer cell lines was associated with the inhibition of hTERT gene expression, hTERT telomerase activity and a number of proteins that regulate hTERT transcriptionally and post-translationally. Furthermore, ablation of hTERT protein increased the sensitivity of cancer cells to CDDO-Me, whereas its overexpression rendered them resistant to CDDO-Me. In addition, inhibition of progression of preneoplastic lesions (i.e., low and high-grade prostate intraepithelial neoplasms, PINs) to adenocarcinoma of the prostate by CDDO-Me in TRAMP mice was associated with significant decrease in TERT and its regulatory proteins in the prostate gland. These data provide evidence that telomerase is a potential target of CDDO-Me for the prevention and treatment of prostate cancer.

Original languageEnglish (US)
Pages (from-to)14795-14809
Number of pages15
JournalMolecules
Volume17
Issue number12
DOIs
StatePublished - Dec 1 2012

Fingerprint

Telomerase
Prostatic Neoplasms
cancer
Cells
proteins
Therapeutics
prostate gland
Prostate
neoplasms
gene expression
apoptosis
Proteins
cultured cells
progressions
Carcinoma in Situ
Cell proliferation
lesions
ablation
mice
Ablation

Keywords

  • Apoptosis
  • CDDO-Me
  • HTERT
  • Prostate cancer
  • Telomerase activity

ASJC Scopus subject areas

  • Organic Chemistry
  • Medicine(all)

Cite this

Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid cddo-me in prostate cancer. / Liu, Yongbo; Gao, Xiaohua; Deeb, Dorrah; Arbab, Ali Syed; Gautam, Subhash C.

In: Molecules, Vol. 17, No. 12, 01.12.2012, p. 14795-14809.

Research output: Contribution to journalArticle

Liu, Yongbo ; Gao, Xiaohua ; Deeb, Dorrah ; Arbab, Ali Syed ; Gautam, Subhash C. / Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid cddo-me in prostate cancer. In: Molecules. 2012 ; Vol. 17, No. 12. pp. 14795-14809.
@article{174c2eba127b46459e6947bc09e7d3d9,
title = "Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid cddo-me in prostate cancer",
abstract = "Methyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate (CDDO-Me) is an synthetic oleanane triterpenoid with strong antiprolifertive and proapoptotic activities in cancer cells. However, the effect of CDDO-Me on human telomerase reverse transcriptase (hTERT) and its telomerase activity in prostate cancer cells has not been studied. We investigated the role of hTERT in mediating the anticancer activity of CDDO-Me in prostate cancer cells in vitro and in vivo. The inhibition of cell proliferation and induction of apoptosis by CDDO-Me in LNCaP and PC-3 prostate cancer cell lines was associated with the inhibition of hTERT gene expression, hTERT telomerase activity and a number of proteins that regulate hTERT transcriptionally and post-translationally. Furthermore, ablation of hTERT protein increased the sensitivity of cancer cells to CDDO-Me, whereas its overexpression rendered them resistant to CDDO-Me. In addition, inhibition of progression of preneoplastic lesions (i.e., low and high-grade prostate intraepithelial neoplasms, PINs) to adenocarcinoma of the prostate by CDDO-Me in TRAMP mice was associated with significant decrease in TERT and its regulatory proteins in the prostate gland. These data provide evidence that telomerase is a potential target of CDDO-Me for the prevention and treatment of prostate cancer.",
keywords = "Apoptosis, CDDO-Me, HTERT, Prostate cancer, Telomerase activity",
author = "Yongbo Liu and Xiaohua Gao and Dorrah Deeb and Arbab, {Ali Syed} and Gautam, {Subhash C.}",
year = "2012",
month = "12",
day = "1",
doi = "10.3390/molecules171214795",
language = "English (US)",
volume = "17",
pages = "14795--14809",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid cddo-me in prostate cancer

AU - Liu, Yongbo

AU - Gao, Xiaohua

AU - Deeb, Dorrah

AU - Arbab, Ali Syed

AU - Gautam, Subhash C.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Methyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate (CDDO-Me) is an synthetic oleanane triterpenoid with strong antiprolifertive and proapoptotic activities in cancer cells. However, the effect of CDDO-Me on human telomerase reverse transcriptase (hTERT) and its telomerase activity in prostate cancer cells has not been studied. We investigated the role of hTERT in mediating the anticancer activity of CDDO-Me in prostate cancer cells in vitro and in vivo. The inhibition of cell proliferation and induction of apoptosis by CDDO-Me in LNCaP and PC-3 prostate cancer cell lines was associated with the inhibition of hTERT gene expression, hTERT telomerase activity and a number of proteins that regulate hTERT transcriptionally and post-translationally. Furthermore, ablation of hTERT protein increased the sensitivity of cancer cells to CDDO-Me, whereas its overexpression rendered them resistant to CDDO-Me. In addition, inhibition of progression of preneoplastic lesions (i.e., low and high-grade prostate intraepithelial neoplasms, PINs) to adenocarcinoma of the prostate by CDDO-Me in TRAMP mice was associated with significant decrease in TERT and its regulatory proteins in the prostate gland. These data provide evidence that telomerase is a potential target of CDDO-Me for the prevention and treatment of prostate cancer.

AB - Methyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate (CDDO-Me) is an synthetic oleanane triterpenoid with strong antiprolifertive and proapoptotic activities in cancer cells. However, the effect of CDDO-Me on human telomerase reverse transcriptase (hTERT) and its telomerase activity in prostate cancer cells has not been studied. We investigated the role of hTERT in mediating the anticancer activity of CDDO-Me in prostate cancer cells in vitro and in vivo. The inhibition of cell proliferation and induction of apoptosis by CDDO-Me in LNCaP and PC-3 prostate cancer cell lines was associated with the inhibition of hTERT gene expression, hTERT telomerase activity and a number of proteins that regulate hTERT transcriptionally and post-translationally. Furthermore, ablation of hTERT protein increased the sensitivity of cancer cells to CDDO-Me, whereas its overexpression rendered them resistant to CDDO-Me. In addition, inhibition of progression of preneoplastic lesions (i.e., low and high-grade prostate intraepithelial neoplasms, PINs) to adenocarcinoma of the prostate by CDDO-Me in TRAMP mice was associated with significant decrease in TERT and its regulatory proteins in the prostate gland. These data provide evidence that telomerase is a potential target of CDDO-Me for the prevention and treatment of prostate cancer.

KW - Apoptosis

KW - CDDO-Me

KW - HTERT

KW - Prostate cancer

KW - Telomerase activity

UR - http://www.scopus.com/inward/record.url?scp=84871541305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871541305&partnerID=8YFLogxK

U2 - 10.3390/molecules171214795

DO - 10.3390/molecules171214795

M3 - Article

VL - 17

SP - 14795

EP - 14809

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 12

ER -